Every nutrient added to a food must make a long journey before it can matter: through processing, through storage, through the acid of the stomach, and into the intestine still intact. Researchers writing in News-Medical are now examining the quiet engineering that tries to protect these ingredients along the way, from tiny lipid shells to gels that release their contents slowly. Yet the review carries a patient humility, reminding us that a promise shown in a test tube or a mouse has not yet become a proven gift to a human body. The question it leaves open is not whether these carriers can wo
Delivery Systems Could Help Functional Foods Protect Bioactives, But Human Evidence Is Still Lacking
Better release in a test tube does not prove a benefit in a person.
Mark
So what's the basic problem these delivery systems are solving?
Mimi
Ingredients break down or fail to absorb. Processing, storage and digestion can all strip activity, and some compounds barely dissolve in water. Carriers wrap or trap them to get them through.
Mark
What are the carriers made of?
Mimi
Mostly proteins, polysaccharides and lipids, shaped into nanoemulsions, liposomes, hydrogels and similar structures. Researchers are also studying casein micelles in milk and seed oleosomes.
Luke
Before we get excited, where does the evidence come from?
Mimi
Mostly simulated digestion, cell cultures and animal studies. The review says human studies are needed.
Mark
The review separates bioaccessibility from bioavailability. Why?
Mimi
One is what's released for absorption; the other is what actually reaches the bloodstream. Improving the first doesn't prove the second.
Luke
And the examples, resveratrol in zein nanoparticles, riboflavin in gels, those are lab results, right?
Mimi
Yes, simulated digestive fluids. They show a mechanism works in a test, not that people benefit.
Mark
Is safety settled?
Mimi
No. Long-term safety of some nanoscale carriers is inadequately assessed, and regulations differ between countries.
Luke
What's still unknown that a shopper would care about?
Mimi
Whether a finished product keeps enough active ingredient and delivers a proper dose per serving. Many formulations haven't left the laboratory.
Le Pouls
- Bioactive ingredients are often lost before they ever reach the gut, leaving functional foods weaker than their labels suggest.
- Engineers are racing to shield fragile compounds with nanoemulsions, liposomes, and hydrogels that release them at the right moment.
- Most of the promising results so far come from digestion simulations, cell cultures, and animal studies rather than people.
- Nanoscale carriers raise unanswered safety questions about long-term exposure, gut function, and the microbes living there.
- Human trials and standardized testing are the path forward, and no health claim can be fully trusted until they arrive.
Every nutrient added to a food must make a long journey before it can matter: through processing, through storage, through the acid of the stomach, and into the intestine still intact. Researchers writing in News-Medical are now examining the quiet engineering that tries to protect these ingredients along the way, from tiny lipid shells to gels that release their contents slowly. Yet the review carries a patient humility, reminding us that a promise shown in a test tube or a mouse has not yet become a proven gift to a human body. The question it leaves open is not whether these carriers can work, but whether their benefits will survive the slower test of real lives.
A vitamin, a polyphenol, or a probiotic placed inside a food faces a difficult passage. It must survive processing and storage, pass the stomach, and arrive in the intestine still active. A News-Medical review examines how food scientists are working to protect these ingredients along the way, and how much of the promise has been tested in people.
Functional foods carry substances such as polyphenols, carotenoids, omega-3 fatty acids, probiotics, and fibers, in drinks, dairy, cereals, and supplements. Many of these ingredients degrade, dissolve poorly, or are barely absorbed. Carotenoids and many polyphenols resist water, and probiotic organisms must endure both shelf life and the gut.
The review separates bioaccessibility, the portion released from food and available for absorption, from bioavailability, the portion that truly enters the bloodstream. A strong result in a simulated digestion does not guarantee a benefit in a person. Some ingredients may only need to act locally in the gut.
To help them, researchers are developing nanoemulsions, liposomes, hydrogels, and other carriers, and even studying the natural structures found in milk and seeds. Each design balances protection against release, since a structure that holds too tightly can keep the ingredient locked away. Some promising examples have emerged in the laboratory, but the review is clear that these results remain early.
Interest in the gut microbiome drives much of this work, yet responses vary with each person's microbes, genetics, diet, and habits. The authors stress that finished foods, not just ingredients, must be judged, and that long-term safety of nanoscale carriers remains poorly understood. Standardized methods and well-designed human trials are the next necessary steps before any firm health claim can be made.
A vitamin, a polyphenol or a probiotic added to a food has to survive a long trip before it can do anything. It has to get through processing, sit on a shelf, pass through the stomach and reach the intestine intact. A News-Medical review of recent research looks at how food scientists are trying to protect those ingredients on the way, and how much of the promise has actually been shown in people.
Functional foods are those containing naturally occurring or added bioactive substances: polyphenols, carotenoids, omega-3 fatty acids, prebiotics, probiotics, fibers, vitamins and minerals. They appear in fortified beverages, dairy products, cereals and snacks, or are sold separately as supplements. The trouble is that some of these ingredients degrade during processing, storage or digestion, and others dissolve poorly or are barely absorbed. Carotenoids and many polyphenols do not mix well with water, and probiotic organisms must stay alive through storage and gut transit.
The review draws a distinction that matters for everything that follows. Bioaccessibility is the fraction of an ingredient released from food and available for absorption. Bioavailability is the fraction actually absorbed and reaching the bloodstream. Better bioaccessibility in a simulated digestion experiment does not prove better bioavailability, or any health benefit, in a person. For ingredients that act locally in the gut, absorption into the body may not be needed at all.
The delivery systems under study include nanoemulsions, liposomes, solid lipid nanoparticles, polymeric nanoparticles, micelles, hydrogels, and several micro- and nanoencapsulation methods. Lipid carriers can disperse ingredients that resist water, while proteins and polysaccharides can form particles, coatings or gel networks that trap compounds and shape their release. Some are built to respond to digestive pH, enzymes or microbial activity. Design involves a trade-off: a structure that holds an ingredient too tightly can limit how much becomes available. Two examples are cited. Zein-based nanoparticles improved the stability and bioaccessibility of resveratrol, and protein-pectin emulsion gels controlled the release of riboflavin and β-carotene in simulated digestive fluids.
Researchers are also looking at structures nature already built. Casein micelles and milk fat globules in milk, and oleosomes, the oil bodies in seeds, are being studied as carriers. Casein micelles form a clot in the stomach, and its gradual breakdown may govern release of the compounds associated with it. Heat treatment and other processing can change that clot and alter release rates.
The gut microbiome, the community of bacteria, viruses, fungi and other microbes, is a major reason for interest. Probiotics, prebiotics, fiber and polyphenols can influence its composition and activity, and microbes help maintain the intestinal barrier, regulate immunity and produce metabolites tied to energy use. The review cautions that fermentability alone does not make a fiber a prebiotic, though inulin and certain fibers can have prebiotic effects. Responses differ with microbiome makeup, genetics, diet and lifestyle, which is why the authors call for clinical evaluation of more personalized approaches. Encapsulation may help probiotics survive storage and transit.
Research is under way on glucose metabolism, insulin sensitivity and body weight, and on possible neuroprotective effects against oxidative damage. The review is blunt that evidence for an ingredient or an experimental carrier does not show that a finished food improves cognition, slows aging or prevents disease. Many formulations are still at laboratory stage, and adding a carrier can change a food's stability, digestion and release. A finished product must be judged on how much active ingredient it retains, how it releases during digestion, and whether a normal serving delivers a suitable dose.
Most evidence so far comes from simulated digestion, cell cultures and animal studies. Long-term safety of new carriers, particularly some nanoscale ones, is inadequately assessed, and must consider carrier composition, dose, exposure time and effects on gut function and microbes. Regulation differs by country, complicating health claims, labeling and approval. Cost, taste, texture and reproducible performance also matter. The review points to standardized testing methods and well-designed human studies as the next steps, with artificial intelligence possibly helping to identify compounds and predict interactions.
Citations marquantes
Improved bioaccessibility in a simulated digestion experiment does not establish improved bioavailability or a health benefit in people.— News-Medical review
Envie de l'histoire complète ?
Lire l'original sur News-Medical ↗
Health & Medicine